Logo image of 1JNJ.MI

JOHNSON & JOHNSON (1JNJ.MI) Stock Overview

BIT:1JNJ - US4781601046 - Common Stock

151.96 EUR
+4.4 (+2.98%)
Last: 9/5/2025, 7:00:00 PM

1JNJ.MI Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap365.97B
Shares2.41B
Float2.41B
Yearly Dividend4.23
Dividend Yield2.91%
EPS(TTM)8.53
PE17.81
Fwd PE15.54
Earnings (Next)10-14 2025-10-14/bmo
IPO09-25 1944-09-25
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


1JNJ.MI short term performance overview.The bars show the price performance of 1JNJ.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

1JNJ.MI long term performance overview.The bars show the price performance of 1JNJ.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1JNJ.MI is 151.96 EUR. In the past month the price increased by 13.98%.

JOHNSON & JOHNSON / 1JNJ Daily stock chart

1JNJ.MI Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 45.85 597.59B
1LLY.MI ELI LILLY & CO 44.76 583.30B
ZEG.DE ASTRAZENECA PLC 18.33 428.02B
JNJ.DE JOHNSON & JOHNSON 17.75 364.67B
RHO.DE ROCHE HOLDING AG-BR 14.51 247.63B
NOT.DE NOVARTIS AG-REG 14.67 211.55B
NOV.DE NOVO NORDISK A/S-B 13.61 201.95B
SAN.PA SANOFI 10.68 196.70B
1SAN.MI SANOFI 10.52 193.75B
SNW.DE SANOFI 10.48 193.07B
6MK.DE MERCK & CO. INC. 10.9 178.84B
1PFE.MI PFIZER INC 7.27 119.42B

About 1JNJ.MI

Company Profile

1JNJ logo image Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 138,100 full-time employees. The firm's primary focus is products related to human health and well-being. The firm operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolism. Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, cardiovascular, and vision fields. These products are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eyecare professionals, and clinics.

Company Info

JOHNSON & JOHNSON

One Johnson & Johnson Plaza

New Brunswick NEW JERSEY US

Employees: 138100

1JNJ Company Website

1JNJ Investor Relations

Phone: 17325242455

JOHNSON & JOHNSON / 1JNJ.MI FAQ

What is the stock price of JOHNSON & JOHNSON today?

The current stock price of 1JNJ.MI is 151.96 EUR. The price increased by 2.98% in the last trading session.


What is the ticker symbol for JOHNSON & JOHNSON stock?

The exchange symbol of JOHNSON & JOHNSON is 1JNJ and it is listed on the Euronext Milan exchange.


On which exchange is 1JNJ.MI stock listed?

1JNJ.MI stock is listed on the Euronext Milan exchange.


What is the price forecast or stock price prediction for JOHNSON & JOHNSON stock?

29 analysts have analysed 1JNJ.MI and the average price target is 155.16 EUR. This implies a price increase of 2.1% is expected in the next year compared to the current price of 151.96. Check the JOHNSON & JOHNSON stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is JOHNSON & JOHNSON worth?

JOHNSON & JOHNSON (1JNJ.MI) has a market capitalization of 365.97B EUR. This makes 1JNJ.MI a Mega Cap stock.


How many employees does JOHNSON & JOHNSON have?

JOHNSON & JOHNSON (1JNJ.MI) currently has 138100 employees.


What are the support and resistance levels for JOHNSON & JOHNSON (1JNJ.MI) stock?

JOHNSON & JOHNSON (1JNJ.MI) has a support level at 141.59 and a resistance level at 157.03. Check the full technical report for a detailed analysis of 1JNJ.MI support and resistance levels.


Is JOHNSON & JOHNSON (1JNJ.MI) expected to grow?

The Revenue of JOHNSON & JOHNSON (1JNJ.MI) is expected to grow by 5.18% in the next year. Check the estimates tab for more information on the 1JNJ.MI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy JOHNSON & JOHNSON (1JNJ.MI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does JOHNSON & JOHNSON (1JNJ.MI) stock pay dividends?

JOHNSON & JOHNSON (1JNJ.MI) has a dividend yield of 2.91%. The yearly dividend amount is currently 4.23. Check the full fundamental report for a detailed analysis of 1JNJ.MI dividend history, reliability and sustainability.


When does JOHNSON & JOHNSON (1JNJ.MI) report earnings?

JOHNSON & JOHNSON (1JNJ.MI) will report earnings on 2025-10-14, before the market open.


What is the Price/Earnings (PE) ratio of JOHNSON & JOHNSON (1JNJ.MI)?

The PE ratio for JOHNSON & JOHNSON (1JNJ.MI) is 17.81. This is based on the reported non-GAAP earnings per share of 8.53 and the current share price of 151.96 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1JNJ.MI.


1JNJ.MI Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to 1JNJ.MI.


Chartmill TA Rating
Chartmill Setup Rating

1JNJ.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to 1JNJ.MI. While 1JNJ.MI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1JNJ.MI Financial Highlights

Over the last trailing twelve months 1JNJ.MI reported a non-GAAP Earnings per Share(EPS) of 8.53. The EPS decreased by -4.58% compared to the year before.


Industry RankSector Rank
PM (TTM) 25%
ROA 11.72%
ROE 28.88%
Debt/Equity 0.61
Chartmill High Growth Momentum
EPS Q2Q%-1.77%
Sales Q2Q%5.77%
EPS 1Y (TTM)-4.58%
Revenue 1Y (TTM)4.68%

1JNJ.MI Forecast & Estimates

29 analysts have analysed 1JNJ.MI and the average price target is 155.16 EUR. This implies a price increase of 2.1% is expected in the next year compared to the current price of 151.96.

For the next year, analysts expect an EPS growth of 9.8% and a revenue growth 5.18% for 1JNJ.MI


Analysts
Analysts72.41
Price Target155.16 (2.11%)
EPS Next Y9.8%
Revenue Next Year5.18%

1JNJ.MI Ownership

Ownership
Inst Owners73.87%
Ins Owners0.04%
Short Float %N/A
Short RatioN/A